Both in Biotechnology
eXoZymes vs Elutia
Over the past year EXOZ returned −66.7% and ELUT returned −16.8%; their daily moves had a correlation of 0.03.
EXOZ −66.7% ELUT −16.8%Growth of $1, one year, split-adjusted
| Metric | EXOZ | ELUT |
|---|---|---|
| Price | $4.50 | $0.7781 |
| Market cap | $41.9M | $34.5M |
| Today | −5.26% | −4.32% |
| 1 month | −18.5% | +0.2% |
| 6 months | −57.3% | −23.7% |
| Year to date | −58.7% | +12.3% |
| 1 year | — | −16.8% |
| Revenue growth (YoY) | — | −11.6% |
| Gross margin | — | 59.6% |
| Net margin | — | −315.0% |
| P/E (TTM) | — | 0.7× |
| Price / sales | — | 2.8× |
| Net cash | $5.6M | $19.9M |
| Dividend yield | — | — |
| Volatility (60d) | 72.4% | 61.4% |
| Short % of float | 0.7% | 0.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).